Kassis S, Olasmaa M, Sullivan M, Fishman P H
J Biol Chem. 1986 Sep 15;261(26):12233-7.
Human A431 and rat glioma C6 cells exposed to isoproterenol underwent a time- and dose-dependent loss of isoproterenol-stimulated adenylate cyclase activity. Desensitization was accompanied by sequestration of beta-adrenergic receptors, which became less accessible to the hydrophilic antagonist 3H-labeled 4-(3-tert-butylamino-2-hydroxypropoxy)benzimidazole-2-one hydrochloride ([3H]CGP-12177) and redistributed from the heavier density plasma membrane fraction to a lighter density membrane fraction. Prior treatment of the cells with concanavalin A or phenylarsine oxide blocked sequestration of the receptors but not desensitization of the agonist-stimulated adenylate cyclase. The membranes from such pretreated cells were exposed to alkali to inactivate adenylate cyclase, and the receptors were transferred to a foreign adenylate cyclase by membrane fusion with polyethylene glycol. beta receptors from desensitized cells exhibited a reduced ability to maximally stimulate the foreign adenylate cyclase, but remained accessible to [3H]CGP-12177 in the fused membranes. When isoproterenol-treated cells were washed free of agonist, there was a time-dependent recovery of agonist responsiveness and [3H]CGP-12177-binding sites. Using the fusion technique, the receptors recovered their functional activity in the resensitized cells. In concanavalin A-treated cells, desensitization and resensitization appeared to occur in the absence of receptor sequestration. Finally, membranes from desensitized cells pretreated with concanavalin A were fused with polyethylene glycol and assayed for agonist-stimulated adenylate cyclase. There was no reversal of the desensitized state. Thus, the primary, essential step in the desensitization process is a reduction in functional activity of the beta-adrenergic receptor. In contrast, sequestration of the receptors is not a prerequisite, but a secondary event during desensitization.
暴露于异丙肾上腺素的人A431细胞和大鼠胶质瘤C6细胞,其异丙肾上腺素刺激的腺苷酸环化酶活性呈现出时间和剂量依赖性的丧失。脱敏伴随着β-肾上腺素能受体的隔离,亲水性拮抗剂3H标记的4-(3-叔丁基氨基-2-羟基丙氧基)苯并咪唑-2-酮盐酸盐([3H]CGP-12177)对其的可及性降低,且受体从较重密度的质膜组分重新分布到较轻密度的膜组分。用伴刀豆球蛋白A或苯砷氧化物预先处理细胞可阻断受体的隔离,但不影响激动剂刺激的腺苷酸环化酶的脱敏。将此类预处理细胞的膜暴露于碱中以灭活腺苷酸环化酶,并通过与聚乙二醇的膜融合将受体转移至外源腺苷酸环化酶。脱敏细胞的β受体最大程度刺激外源腺苷酸环化酶的能力降低,但在融合膜中仍可被[3H]CGP-12177识别。当用异丙肾上腺素处理的细胞洗去激动剂后,激动剂反应性和[3H]CGP-12177结合位点呈现出时间依赖性的恢复。使用融合技术,受体在再敏化细胞中恢复其功能活性。在伴刀豆球蛋白A处理的细胞中,脱敏和再敏化似乎在没有受体隔离的情况下发生。最后,将用伴刀豆球蛋白A预处理的脱敏细胞的膜与聚乙二醇融合,并检测激动剂刺激的腺苷酸环化酶。脱敏状态没有逆转。因此,脱敏过程中的主要关键步骤是β-肾上腺素能受体功能活性的降低。相比之下,受体的隔离不是必需条件,而是脱敏过程中的次要事件。